164 related articles for article (PubMed ID: 3435698)
21. Cytotoxic activity of daunorubicin or vindesin conjugated to a monoclonal antibody on cultured MCF-7 breast carcinoma cells.
Aboud-Pirak E; Lesur B; Rao KS; Baurain R; Trouet A; Schneider YJ
Biochem Pharmacol; 1989 Feb; 38(4):641-8. PubMed ID: 2917019
[TBL] [Abstract][Full Text] [Related]
22. [Chemotherapy of metastasizing cancers of the colon and rectum].
Piedbois P; Lévy E; Le Bourgeois JP; Buyse M
Ann Chir; 1993; 47(6):480-3. PubMed ID: 7692804
[No Abstract] [Full Text] [Related]
23. Antigenicity of newly established colorectal carcinoma cell lines.
Durrant LG; Robins RA; Pimm MV; Perkins AC; Armitage NC; Hardcastle JD; Baldwin RW
Br J Cancer; 1986 Jan; 53(1):37-45. PubMed ID: 3947514
[TBL] [Abstract][Full Text] [Related]
24. [Chemotherapy of cancer of the large intestine].
Platinskiĭ LV; Sokolova VD; Ozhiganov EL
Sov Med; 1985; (3):51-8. PubMed ID: 3895460
[No Abstract] [Full Text] [Related]
25. In vitro chemotherapy sensitivity patterns of human colon carcinoma continuous cell lines.
Agrez MV; Ames MM; Lieber MM
J Surg Oncol; 1983 Sep; 24(1):79-82. PubMed ID: 6887942
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy of colorectal cancer.
Klaassen DJ
Can J Surg; 1978 May; 21(3):218-20. PubMed ID: 647512
[TBL] [Abstract][Full Text] [Related]
27. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
28. Experience in the preparation and experimental use of immunocytostatics.
Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
[TBL] [Abstract][Full Text] [Related]
29. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
Johnston PG; Drake JC; Trepel J; Allegra CJ
Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
[TBL] [Abstract][Full Text] [Related]
30. NCCN guideline updates: colon and rectal cancers, version 1.2004.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 Jul; 2(4):284-5. PubMed ID: 19795595
[No Abstract] [Full Text] [Related]
31. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of single-agent therapy in human colorectal tumour xenografts.
Houghton PJ; Houghton JA
Br J Cancer; 1978 May; 37(5):833-40. PubMed ID: 656310
[TBL] [Abstract][Full Text] [Related]
33. Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
Durrant LG; Robins RA; Ballantyne KC; Marksman RA; Hardcastle JD; Baldwin RW
Br J Cancer; 1989 Dec; 60(6):855-60. PubMed ID: 2481485
[TBL] [Abstract][Full Text] [Related]
34. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay.
Park JG; Kramer BS; Steinberg SM; Carmichael J; Collins JM; Minna JD; Gazdar AF
Cancer Res; 1987 Nov; 47(22):5875-9. PubMed ID: 3664487
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody.
Farrands PA; Perkins AC; Pimm MV; Embleton MJ; Hardy JD; Baldwin RW; Hardcastle JD
Lancet; 1982 Aug; 2(8295):397-400. PubMed ID: 6124802
[TBL] [Abstract][Full Text] [Related]
36. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
Pietersz GA; Smyth MJ; McKenzie IF
Cancer Res; 1988 Feb; 48(4):926-31. PubMed ID: 3422182
[TBL] [Abstract][Full Text] [Related]
37. The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours.
Armitage NC; Perkins AC; Pimm MV; Farrands PA; Baldwin RW; Hardcastle JD
Br J Surg; 1984 Jun; 71(6):407-12. PubMed ID: 6372936
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 2'-deoxyuridine and 5-fluoro-2'-deoxyuridine derivatives and evaluation in antibody targeting studies.
Henn TF; Garnett MC; Chhabra SR; Bycroft BW; Baldwin RW
J Med Chem; 1993 May; 36(11):1570-9. PubMed ID: 8496926
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
40. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
